Los Angeles Capital Management
WVE icon

Los Angeles Capital Management’s Wave Life Sciences WVE Stock Holding History

Los Angeles Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$608K Buy
+104,705
New +$694K ﹤0.01% 859
2025
Q1 		– Sell
-24,461
Closed -$303K – 1246
2024
Q4 		$303K Buy
+24,461
New +$327K ﹤0.01% 929
2021
Q2 		– Sell
-13,050
Closed -$73K – 1686
2021
Q1 		$73K Buy
+13,050
New +$125K ﹤0.01% 1569
2019
Q2 		– Sell
-6,330
Closed -$246K – 1439
2019
Q1 		$246K Buy
+6,330
New +$257K ﹤0.01% 1258

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Los Angeles Capital Management's WVE Position: Q2 2026 in Review

Los Angeles Capital Management opened a new position in Wave Life Sciences (WVE) in Q2 2026: 104,705 shares worth $608K. The stake represents ﹤0.01% of the portfolio and ranks #859 among its holdings. This is a return to the name: Los Angeles Capital Management previously reported a position in WVE as recently as Q4 2024.

Los Angeles Capital Management first reported a position in WVE in Q1 2019 and has held it in 4 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Los Angeles Capital Management held 104,705 shares of Wave Life Sciences worth $608K as of Q2 2026.
  • Wave Life Sciences was a new Los Angeles Capital Management position in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #859 holding.
  • Los Angeles Capital Management first reported a position in Wave Life Sciences in Q1 2019 and has held it in 4 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.